bay-k-8644 and h 89

bay-k-8644 has been researched along with h 89 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's2 (28.57)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J1
Lambert, DG; Smart, D1
Kobayashi, D; Miyamoto, K; Ohmae, S; Sanae, F; Takag, K1
Giuliani, S; Maggi, CA; Santicioli, P1
Iwata, S; Kon-ya, K; Ohizumi, Y; Saito, S; Shizuri, Y1
Bryant, S; Chase, A; James, AF; Kimura, TE; Kong, CH; Orchard, CH; Suleiman, MS; Watson, JJ1
Bova, S; Fusi, F; Sgaragli, G; Spiga, O; Trezza, A1

Other Studies

7 other study(ies) available for bay-k-8644 and h 89

ArticleYear
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
    Nature chemical biology, 2009, Volume: 5, Issue:10

    Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection

2009
Desensitization of the mu-opioid activation of phospholipase C in SH-SY5Y cells: the role of protein kinases C and A and Ca(2+)-activated K+ currents.
    British journal of pharmacology, 1995, Volume: 116, Issue:6

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Analgesics, Opioid; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Cyclic AMP-Dependent Protein Kinases; Enzyme Activation; Enzyme Inhibitors; Fentanyl; Humans; Indoles; Inositol 1,4,5-Trisphosphate; Isoquinolines; Narcotics; Neuroblastoma; Nifedipine; Potassium Channels; Protein Kinase C; Receptors, Opioid, mu; Sensitivity and Specificity; Sulfonamides; Tumor Cells, Cultured; Type C Phospholipases

1995
Negative inotropic action of denbufylline through interfering with the calcium channel independently of its PDE IV inhibitory activity in guinea pig ventricle papillary muscles.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 277, Issue:1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Azides; Caffeine; Calcium Channels; Depression, Chemical; Dihydropyridines; Guinea Pigs; In Vitro Techniques; Isoquinolines; Male; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Ryanodine; Sulfonamides; Xanthines

1996
CGRP inhibition of electromechanical coupling in the guinea-pig isolated renal pelvis.
    Naunyn-Schmiedeberg's archives of pharmacology, 1995, Volume: 352, Issue:5

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Arginine; Calcitonin Gene-Related Peptide; Calcium; Carbazoles; Enzyme Inhibitors; Glyburide; Guinea Pigs; In Vitro Techniques; Indoles; Isoquinolines; Kidney Pelvis; Male; Membrane Potentials; Nitroarginine; Potassium Channels; Ryanodine; Sucrose; Sulfonamides; Terpenes; Tetrodotoxin; Thapsigargin

1995
Novel marine-derived halogen-containing gramine analogues induce vasorelaxation in isolated rat aorta.
    European journal of pharmacology, 2001, Nov-30, Volume: 432, Issue:1

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Alkaloids; Animals; Aorta, Thoracic; Caffeine; Calcium; Calcium Channel Agonists; Dose-Response Relationship, Drug; In Vitro Techniques; Indole Alkaloids; Indoles; Isoquinolines; Male; Phenylephrine; Potassium; Rats; Rats, Wistar; Sulfonamides; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation

2001
Stimulation of ICa by basal PKA activity is facilitated by caveolin-3 in cardiac ventricular myocytes.
    Journal of molecular and cellular cardiology, 2014, Volume: 68

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adrenergic beta-2 Receptor Agonists; Animals; Calcium Channels, L-Type; Calcium Signaling; Caveolin 3; Cyclic AMP-Dependent Protein Kinases; Ethanolamines; Heart Ventricles; Isoquinolines; Male; Myocytes, Cardiac; Patch-Clamp Techniques; Phosphorylation; Protein Binding; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Rats; Rats, Wistar; Sarcolemma; Sulfonamides

2014
Ca
    Biochemical pharmacology, 2017, 09-15, Volume: 140

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Binding Sites; Calcium Channel Blockers; Calcium Channels, L-Type; Carbazoles; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Electrophysiological Phenomena; In Vitro Techniques; Intracellular Signaling Peptides and Proteins; Isoquinolines; Male; Models, Molecular; Molecular Docking Simulation; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Patch-Clamp Techniques; Peptide Fragments; Protein Kinase Inhibitors; Pyrroles; Rats, Wistar; Sulfonamides; Tail; Vasodilation

2017